GLP-1 receptor agonist attenuates tubular cell ferroptosis in diabetes via enhancing AMPK-fatty acid metabolism pathway through macropinocytosis
- 12 February 2024
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1870 (4) , 167060
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82270760)
- Natural Science Foundation of Jiangsu Province (82200802)
This publication has 66 references indexed in Scilit:
- The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetesCell Metabolism, 2023
- Autophagy-Dependent Ferroptosis: Machinery and RegulationCell Chemical Biology, 2020
- Transient Receptor Potential V Channels Are Essential for Glucose Sensing by Aldolase and AMPKCell Metabolism, 2019
- Ferroptosis is a lysosomal cell death processBiochemical and Biophysical Research Communications, 2018
- Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and DiseaseCell, 2017
- Oxidative stress activates AMPK in cultured cells primarily by increasing cellular AMP and/or ADPFEBS Letters, 2014
- Small Molecule Drug A-769662 and AMP Synergistically Activate Naive AMPK Independent of Upstream Kinase SignalingChemistry & Biology, 2014
- p70S6 Kinase Phosphorylates AMPK on Serine 491 to Mediate Leptin's Effect on Food IntakeCell Metabolism, 2012
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetesDiabetologia, 2011